Matthew B. Yurgelun

Also affiliated with Harvard University, Dana-Farber Cancer Institute, Cancer Genetics (United States), Dana-Farber Brigham Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial”.

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-022-02181-8

N/A

4.9DataRank · unranked

192 citations

Jonathan Chen, Sherry Chao, Karin Pelka, Marios Giannakis, Julian M. Hess +40 more

Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-51271-3

N/A

0.654DataRank · unranked

17 citations

Kristen E. Lowder, Kevin S. Kapner, Ronan J. Kelly, Hui Zheng, Nadine J. McCleary +20 more

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study

Gastroenterology(2024)10.1053/j.gastro.2024.01.042

N/A

0.624DataRank · unranked

18 citations

C. Sloane Furniss, Matthew B. Yurgelun, Chinedu Ukaegbu, Pamela E. Constantinou, Ileana Fortes +23 more

Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing SMAD4/BMPR1A Variant

Cancer Prevention Research(2020)10.1158/1940-6207.capr-20-0348

N/A

0.581DataRank · unranked

47 citations

Jessica Ebrahimzadeh, Kristin Zelley, Lubna Begum, Lee M. Bass, Randall E. Brand +18 more

Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3930

N/A

0.581DataRank · unranked

47 citations

Rachel B. Keller, Kevin S. Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan +27 more

Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study

BMJ Open Sport & Exercise Medicine(2022)10.1136/bmjsem-2022-001353

N/A

0.434DataRank · unranked

8 citations

Elizabeth Brighton, Nancy Campbell, Nadine J. McCleary, Thomas A. Abrams, James M. Cleary +7 more

Lynch Syndrome

Hereditary Colorectal Cancer(2018)10.1007/978-3-319-74259-5_1

N/A

0.104DataRank · unranked

1 citations

Matthew B. Yurgelun, C. Richard Boland, Elena M. Stoffel

Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report

Journal of Gastrointestinal Oncology(2021)10.21037/jgo-21-197

N/A

0DataRank · unranked

4 citations

Brian M. Wolpin, Ilana S. Warsofsky, David P. Ryan, Kimberly Perez, Osama E. Rahma +7 more

Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.22.509032

N/A

0DataRank · unranked

8 citations

Jonathan Rennhack, Daulet Aitymbayev, Clare Morris, Sydney M. Moyer, Gina N. Duronio +8 more

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1579

N/A

0DataRank · unranked

1 citations

Hajime Uno, C. Sloane Furniss, Chinedu Ukaegbu, Miki Horiguchi, Anu Chittenden +6 more

Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

Nature Communications(2023)10.1038/s41467-023-40024-3

N/A

0DataRank · unranked

68 citations

Michael H. Rosenthal, Tilak Sundaresan, Natalia Khalaf, Valerie Lee, Lauren K. Brais +20 more

Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer

The Oncologist(2023)10.1093/oncolo/oyad002

N/A

0DataRank · unranked

7 citations

Anna M. Chiarella, James M. Cleary, Nora Horick, Colin D. Weekes, Thomas A. Abrams +21 more

Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2023.01.035

N/A

0DataRank · unranked

5 citations

Miki Horiguchi, Hajime Uno, Chinedu Ukaegbu, Anu Chittenden, Nicole R. LeBoeuf +4 more

PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer

Familial Cancer(2023)10.1007/s10689-023-00345-0

N/A

0DataRank · unranked

4 citations

Miki Horiguchi, Chinedu Ukaegbu, C. Sloane Furniss, Hajime Uno, Sapna Syngal +2 more

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1073

N/A

0DataRank · unranked

28 citations

Andressa Dias Costa, Emily Kawaler, Victoire Cardot‐Ruffino, Osama E. Rahma, Nina Beri +36 more

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.678

N/A

0DataRank · unranked

2 citations

Anu Chittenden, Chinedu Ukaegbu, Kimberly Perez, Audrey Madigan, Shraddha Gaonkar +5 more

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals

Familial Cancer(2020)10.1007/s10689-020-00198-x

N/A

0DataRank · unranked

9 citations

Zohar Levi, Tara Fehlmann, Hajime Uno, Anu Chittenden, Jennifer Inra +5 more

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008436

N/A

0DataRank · unranked

13 citations

Harshabad Singh, Lestat R. Ali, Nora Horick, S. Jennifer Wang, Megan T. Hoffman +33 more

Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study

Cancer Prevention Research(2021)10.1158/1940-6207.capr-20-0642

N/A

0DataRank · unranked

23 citations

Matthew B. Yurgelun, Chinedu Ukaegbu, Pamela E. Constantinou, Catherine C. Lafferty, Eliana R. Talcove-Berko +23 more

Letter to the Editor-Recent advances in Lynch syndrome: response to Møller et al.

Familial Cancer(2020)10.1007/s10689-020-00199-w

N/A

0DataRank · unranked

1 citations

Sapna Syngal, Matthew B. Yurgelun, Leah H. Biller

Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome

Gastroenterology(2021)10.1053/j.gastro.2021.03.039

N/A

0DataRank · unranked

19 citations

Miki Horiguchi, Hajime Uno, Chinedu Ukaegbu, Sapna Syngal, Matthew B. Yurgelun +1 more